KDP vs ZBIO · P/E 23, rev $11.29B vs rev $10.0M
Keurig Dr Pepper Inc (KDP) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported KDP revenue for 2026-06-30 was $11.29B. Net income was $412.0M. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
KDP currently screens at market cap $42.03B and trailing P/E 22.9. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the KDP and ZBIO stock pages for the full models.
Not investment advice.